Search Results - Sharifian, Ramezanali

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Down-regulation of immune checkpoints by doxorubicin and carboplatin-containing neoadjuvant regimens in a murine breast cancer model

    Down-regulation of immune checkpoints by doxorubicin and carboplatin-containing neoadjuvant regimens in a murine breast cancer model by Sadighi, Sanambar, Sharifian, Ramezanali, Kazemimanesh, Monireh, Muhammadnejad, Ahad, Shahosseini, Zahra, Amanpour, Saeid, Muhammadnejad, Samad

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Combination of cyclophosphamide, etoposide, carboplatin and dexamethasone as a salvage regimen for refractory multiple myeloma patients: a comparison with a historical control group

    Combination of cyclophosphamide, etoposide, carboplatin and dexamethasone as a salvage regimen for refractory multiple myeloma patients: a comparison with a historical control grou... by Safaee, Reza, Ahmadzadeh, Ahmad, Sharifian, Ramezanali, Emami, Amirhossein, Yekaninejad, Mir Saeed, Jalili, Mohammad Hossein, Valizadeh, Armita

    Published in Hematology reports
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    N-acetyl cysteine in prevention of amphotericin- induced electrolytes imbalances: a randomized, double-blinded, placebo-controlled, clinical trial

    N-acetyl cysteine in prevention of amphotericin- induced electrolytes imbalances: a randomized, double-blinded, placebo-controlled, clinical trial by Karimzadeh, Iman, Khalili, Hossein, Dashti-Khavidaki, Simin, Sharifian, Ramezanali, Abdollahi, Alireza, Hasibi, Mehrdad, Khazaeipour, Zahra, Farsaei, Shadi

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Intensified versus non-intensified induction therapy with cytarabine and daunorubicin for patients with newly diagnosed acute myeloid leukemia

    Intensified versus non-intensified induction therapy with cytarabine and daunorubicin for patients with newly diagnosed acute myeloid leukemia by Mirzania, Mehrzad, Safaee Nodehi, SayyedReza, Sharifian, RamezanAli, Shahi, Farhad, Emami, AmirHosein, Esfandbod, Mohsen, Togeh, GholamReza, Tavakoli, Sahar

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: